Profil
Lauren Merendino is currently Chief Commercial Officer at Day One Biopharmaceuticals, Inc. since 2023.
Former roles include Independent Non-Executive Director at ESSA Pharma, Inc. from 2023 to 2025, Vice President-Neurological Rare Diseases at Genentech, Inc. from 2018 to 2021, and Chief Commercial Officer at Myovant Sciences, Inc. and Myovant Sciences Ltd. Education includes an MBA from New York University and an undergraduate degree from The Pennsylvania State University.
Postes actifs de Lauren Merendino
| Sociétés | Poste | Début |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2023 |
Anciens postes connus de Lauren Merendino
| Sociétés | Poste | Fin |
|---|---|---|
| ESSA PHARMA INC. | Directeur/Membre du Conseil | 05/03/2025 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/04/2021 |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Corporate Officer/Principal | - |
| MYOVANT SCIENCES LTD. | Corporate Officer/Principal | - |
Formation de Lauren Merendino
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSA Pharma, Inc.
ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
Myovant Sciences Ltd.
Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
















